Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Andrea Di Giorgio
Observed names:
A Di Giorgio,
ANDREA DI GIORGIO,
Di Giorgio, Andrea
Institutions:
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola,
University of Bologna
Observed institutions:
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola,
University of Bologna
ORCID:
0009-0006-3973-4409
Observed ORCID:
0009-0006-3973-4409
OpenAlex ID:
A5128716255
New prostate cancer risk groups by PSMA-PET (PPP3): an international, retrospective, registry-based cohort study
2026
·
Madeleine J Karpinski
, Caner Civan
, et al.
·
The Lancet Oncology
·
14
PDF
Joint survey by AIMN, AIOM, AIRO, SIU, SIUrO, and Meet-URO about the use of PSMA PET imaging in prostate cancer in Italy: PSA persistence, biochemical recurrence, hormone-sensitive and castration-resistant metastatic settings
2026
·
Matteo Bauckneht
, Laura Evangelista
, et al.
·
Clinical and Translational Imaging
·
3
PDF
PSMA-PET imaging in prostate cancer patients with high-risk biochemical recurrence: implications from an “EMBARK-Like” cohort
2026
·
Matteo Droghetti
, Valerio Pirelli
, et al.
·
Prostate Cancer and Prostatic Diseases
·
3
PSMA PET/CT–Targeted Biopsy in Men with Negative or Equivocal Multiparametric MRI and Exploratory Dynamic Total-Body PET: The FUPERMAN Study
2026
·
Andrea Farolfi
, Caterina Maria Paola Sgro
, et al.
·
Journal of Nuclear Medicine
·
2
PDF
Salvage Radiotherapy Confers an Overall Survival Advantage in Biochemical Recurrence of Prostate Cancer: Evidence from the International PROMISE Registry
2026
·
Nika Guberina
, Madeleine J. Karpinski
, et al.
·
Journal of Nuclear Medicine
·
1
PDF
PSMA Total Tumor Volume: A Simple Quantifiable Biomarker for Overall Survival Prediction—Results from the International PROMISE PET Registry
2026
·
Madeleine J. Karpinski
, Caner Civan
, et al.
·
Journal of Nuclear Medicine
PDF
VAULT 2: anonymized patient-level dataset – Intra-patient comparison of total-body vs. conventional [68Ga]Ga-PSMA-11 PET/CT in early biochemical recurrence of prostate cancer
2026
·
Di Giorgio, Andrea
, FANTI, STEFANO
·
Zenodo (CERN European Organization for Nuclear Research)
The role of extracardiac radiotracer biodistribution in the evaluation of cardiac amyloidosis: a retrospective multicenter study on [99mTc]Tc-DPD and [99mTc]Tc-HMDP
2026
·
Andrea Di Giorgio
, Giacomo Battisti
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
PDF
Prognostic value of different metabolic response criteria in patients with advanced melanoma treated with immunotherapy: a comparative analysis of PECRIT, PERCIMT, and EORTC criteria
2026
·
Andrea Di Giorgio
, Francesca Comito
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
Total-Body PET in Theranostics: Reshaping Treatment Planning and Follow-Up
2026
·
Andrea Di Giorgio
, Martina Di Franco
, et al.
·
PET Clinics
Assoziation zwischen PRIMARY-Score und Gesamtüberleben bei der Stadieneinteilung mittels PSMA-PET bei Patienten mit neu diagnostiziertem Prostatakrebs: Ergebnisse des internationalen, multizentrischen PROMISE-Registers
2026
·
M Karpinski
, S Hoberück
, et al.
·
Nuklearmedizin - NuclearMedicine
Neue Risikogruppen für Prostatakrebs anhand der PSMA-PET (PPP3)
2026
·
J Enste
, M Karpinski
, et al.
·
Nuklearmedizin - NuclearMedicine
Omitted staging PSMA PET/CT is associated with advance disease extent at time of PSA persistence: a single center retrospective analysis
2026
·
Andrea Di Giorgio
, Marco Rapa
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
PDF
Diagnostic Value and Clinical Applications of Psma Pet/ct in Primary Staging of Prostate Cancer
2026
·
ANDREA DI GIORGIO
, MARCO RAPA
, et al.
·
Turkiye Klinikleri eBooks
Post-treatment Monitoring and Evaluation
2026
·
MARCO RAPA
, ANDREA DI GIORGIO
, et al.
·
Turkiye Klinikleri eBooks
Show more works
View as search
Works count:
15
Citation count:
23
H-index:
3
I10-index:
1
Year
Topic
Type